Cited by 355CRISPR and Genetic EngineeringRNA regulation and diseaseVirus-based gene therapy research

Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes

Open access
Staahl, Brett T, Benekareddy, Madhurima, Coulon-Bainier, Claire, Banfal, Ashwin A, Floor, Stephen N, Sabo, Jennifer K, Urnes, Cole, Munares, Gabriela Acevedo +2 more·2017·Nature Biotechnology

Abstract

We demonstrate editing of post-mitotic neurons in the adult mouse brain following injection of Cas9 ribonucleoprotein (RNP) complexes in the hippocampus, striatum and cortex. Engineered variants of Cas9 with multiple SV40 nuclear localization sequences enabled a tenfold increase in the efficiency of neuronal editing in vivo. These advances indicate the potential of genome editing in the brain to correct or inactivate the underlying genetic causes of neurological diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nbt.3806

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Direct application of pre-assembled CRISPR-Cas RNPs can reduce possible off-target mutations relative to delivering Cas9-encoding DNA or mRNA due to the short half-life of RNPs.

    “This delivery mode can reduce possible off-target mutations relative to delivering Cas9-encoding DNA or mRNA due to the short half-life of RNPs 76,85-87 .”

    From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [76]

    The Abstract (page unavailable) says that off-target editing is a concern with genetically encoded Cas9 delivered by viral vectors or plasmids, and that short-lived, preassembled Cas9 RNPs overcome this concern. It does not make the same comparison with Cas9-encoding mRNA, so that part of the claim is unsupported. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • The total number of cells counted from every 4th DAPI stained brain slice was multiplied by 12 to obtain the estimate of the total number of tdTomato+; DAPI+ cells in the striatum or hippocampus, as similar to previously reported methods.

    “Then, the total number of cells counted from every 4th DAPI stained brain slice was multiplied by 12 to obtain the estimate of the total number of tdTomato+; DAPI+ cells in the striatum or hippocampus, as similar to previously reported methods (37).”

    From Lipid Nanoparticles Deliver mRNA to the Brain after an Intracerebral Injection (2023) · cites this paper as [37]

    The Additional information cell-counting passage describes staining sampled brain sections with DAPI, counting tdTomato/DAPI double-positive cells, and scaling the count by section periodicity. That supports the claimed similarity of method, but this paper sampled every sixth dorsal-striatum section and multiplied by 6—not every fourth section and multiplied by 12. The cited passage does not describe this counting procedure for the hippocampus. No page number is provided in our copy. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • Disadvantages of LNP delivery include significant toxicity and sometimes undesired selectivity of cell-type specific uptake.

    “Disadvantages of this approach include significant toxicity of the LNPs 76 and the sometimes undesired selectivity of cell-type specific uptake of the particles.”

    From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [76]

  • Direct injection of 4xNLS-Cas9-2xNLS RNPs into the striatum and hippocampus of Ai14 mice edited genes in brain tissue efficiently.

    “Specifically, Staahl et al. (2017) demonstrated that direct injection of the Cas9 protein fused to 6 SV40 nuclear localization signals (4xNLS-Cas9–2xNLS), complexed to sgRNA (4xNLS-Cas9–2xNLS RNPs) into the striatum and hippocampus of Ai14 mice was able to edit genes in brain tissue efficiently (37).”
  • MC3 LNP Cas9 mRNA/Ai9 sgRNA demonstrates similar or better local transfection efficiency in the striatum and the hippocampus compared to previously demonstrated results using Cas9 RNPs (37, 43).

    “MC3 LNP Cas9 mRNA/Ai9 sgRNA demonstrates similar or better local transfection efficiency in the striatum and the hippocampus compared to previously demonstrated results using Cas9 RNPs (37, 43).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 30 · Cited by 355

Authors
Staahl, B. T., Benekareddy, M., Coulon-Bainier, C., Banfal, A. A., Floor, S. N., Sabo, J. K., Urnes, C., Munares, G. A., Ghosh, A., & Doudna, J. A.
Affiliations
  • University of California, Berkeley (US)
  • F. Hoffmann-La Roche AG (CH)
  • Howard Hughes Medical Institute (US)
Corresponding author
Doudna, Jennifer A
Venue
Nature Biotechnology
Published
2017-02-13
Volume
35
Issue
5
Pages
431-434
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W2588309240
Cited by
355
References
30
Citations by year
2026: 23 · 2025: 36 · 2024: 29 · 2023: 40 · 2022: 35 · 2021: 29 · 2020: 45 · 2019: 39 · 2018: 58 · 2017: 19 · 2013: 1 · 2012: 1
FWCI
17.97
Type
journal article
Language
en
Open access
Locations
  • Nature Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Howard Hughes Medical Institute
  • F. Hoffmann-La Roche
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
genome editing, Cas9 ribonucleoprotein, nuclear localization signal, postmitotic neurons, adult mouse brain, hippocampus, striatum, cerebral cortex, in vivo gene delivery, neurological disease therapy
MeSH terms
Gene Editing, CRISPR-Associated Protein 9, Animals, Bacterial Proteins, Brain, Endonucleases, Male, Nerve Tissue Proteins, Ribonucleoproteins, Protein Engineering, Gene Targeting, Mice, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Associated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review